Breaking News Instant updates and real-time market news.

EBAY

eBay

$39.22 /

+0.25 (+0.64%)

06:53
10/24/19
10/24
06:53
10/24/19
06:53

eBay price target lowered to $33 from $36 at Mizuho

Mizuho analyst James Lee lowered his price target for eBay to $33 from $36 saying that while the company beat on earnings last night due to its ongoing reduction in marketing costs, overall gross merchandise volume growth "remained sluggish" due to headwinds on lower marketing activities and from internet tax. The analyst reduced his 2021 earnings per share estimate to $2.80 from $3.03 and keeps an Underperform rating on eBay. Lee is concerned about the company's ability to grow gross merchandise volume and the search for a permanent CEO.

  • 27

    Oct

  • 29

    Oct

OTHER BREAKING NEWS FROM THE FLY

Recommendations
Xos price target lowered to $5 from $11 at DA Davidson » 07:42
08/12/22
08/12
07:42
08/12/22
07:42
XOS

Xos

$1.99 /

-0.09 (-4.33%)

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XOS Xos
$1.99 /

-0.09 (-4.33%)

XOS Xos
$1.99 /

-0.09 (-4.33%)

07/15/22 Northland
Sunworks and Sunnova could trade down on Manchin news, says Northland
06/03/22 Northland
Xos initiated with an Outperform at Northland
12/08/21 BofA
Xos initiated with an Underperform at BofA
12/02/21 Goldman Sachs
Xos initiated with a Neutral at Goldman Sachs
XOS Xos
$1.99 /

-0.09 (-4.33%)

XOS Xos
$1.99 /

-0.09 (-4.33%)

Recommendations
Privia Health price target raised to $44 from $35 at Cowen » 07:41
08/12/22
08/12
07:41
08/12/22
07:41
PRVA

Privia Health

$37.81 /

+1.42 (+3.90%)

Cowen analyst Gary Taylor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRVA Privia Health
$37.81 /

+1.42 (+3.90%)

PRVA Privia Health
$37.81 /

+1.42 (+3.90%)

07/14/22 Truist
Privia Health price target raised to $40 from $36 at Truist
06/29/22 Canaccord
Privia Health price target raised to $40 from $29 at Canaccord
05/13/22 Canaccord
Privia Health price target lowered to $29 from $44 at Canaccord
05/03/22 BofA
BofA starts Privia Health at Buy as value-based care play
PRVA Privia Health
$37.81 /

+1.42 (+3.90%)

  • 19
    Nov
PRVA Privia Health
$37.81 /

+1.42 (+3.90%)

Recommendations
Sanofi may not be liable for any Zantac litigation damages, says JPMorgan » 07:40
08/12/22
08/12
07:40
08/12/22
07:40
SNY

Sanofi

$43.46 /

-1.74 (-3.85%)

, GSK

GSK plc

$35.75 /

-2.57 (-6.71%)

, HLN

Haleon

$6.29 /

-0.22 (-3.38%)

, PFE

Pfizer

$48.31 /

-1.62 (-3.24%)

JPMorgan analysts Richard…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$43.46 /

-1.74 (-3.85%)

GSK GSK plc
$35.75 /

-2.57 (-6.71%)

HLN Haleon
$6.29 /

-0.22 (-3.38%)

PFE Pfizer
$48.31 /

-1.62 (-3.24%)

SNY Sanofi
$43.46 /

-1.74 (-3.85%)

05:33 Today Deutsche Bank
Sanofi upgraded to Hold from Sell at Deutsche Bank
08/11/22 JPMorgan
Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan
08/11/22 Deutsche Bank
Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank
08/09/22 UBS
Sanofi downgraded to Neutral from Buy at UBS
GSK GSK plc
$35.75 /

-2.57 (-6.71%)

08/11/22 JPMorgan
Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan
08/11/22 Deutsche Bank
Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank
08/09/22 Baird
Mersana Therapeutics price target raised to $20 from $18 at Baird
08/08/22 UBS
GSK plc price target lowered to 1,820 GBp from 1,860 GBp at UBS
HLN Haleon
$6.29 /

-0.22 (-3.38%)

08/11/22 JPMorgan
Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan
08/11/22 Deutsche Bank
Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank
07/29/22 Deutsche Bank
Haleon initiated with a Hold at Deutsche Bank
07/25/22 Goldman Sachs
Haleon initiated with a Buy at Goldman Sachs (last week)
PFE Pfizer
$48.31 /

-1.62 (-3.24%)

08/11/22 JPMorgan
Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan
08/11/22 Deutsche Bank
Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank
08/09/22 Wells Fargo
Global Blood Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo
08/08/22 Cantor Fitzgerald
Global Blood downgraded to Neutral from Overweight at Cantor Fitzgerald
SNY Sanofi
$43.46 /

-1.74 (-3.85%)

GSK GSK plc
$35.75 /

-2.57 (-6.71%)

PFE Pfizer
$48.31 /

-1.62 (-3.24%)

SNY Sanofi
$43.46 /

-1.74 (-3.85%)

GSK GSK plc
$35.75 /

-2.57 (-6.71%)

HLN Haleon
$6.29 /

-0.22 (-3.38%)

PFE Pfizer
$48.31 /

-1.62 (-3.24%)

SNY Sanofi
$43.46 /

-1.74 (-3.85%)

GSK GSK plc
$35.75 /

-2.57 (-6.71%)

HLN Haleon
$6.29 /

-0.22 (-3.38%)

PFE Pfizer
$48.31 /

-1.62 (-3.24%)

GSK GSK plc
$35.75 /

-2.57 (-6.71%)

HLN Haleon
$6.29 /

-0.22 (-3.38%)

PFE Pfizer
$48.31 /

-1.62 (-3.24%)

Recommendations
ForgeRock price target lowered to $25 from $28 at Cowen » 07:39
08/12/22
08/12
07:39
08/12/22
07:39
FORG

ForgeRock

$22.24 /

-1.13 (-4.84%)

Cowen analyst Shaul Eyal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FORG ForgeRock
$22.24 /

-1.13 (-4.84%)

FORG ForgeRock
$22.24 /

-1.13 (-4.84%)

07/13/22 Piper Sandler
ForgeRock price target raised to $25 from $24 at Piper Sandler
06/22/22 JPMorgan
ForgeRock price target lowered to $30 from $36 at JPMorgan
05/12/22 Deutsche Bank
ForgeRock price target lowered to $15 from $16 at Deutsche Bank
05/12/22 Mizuho
ForgeRock price target lowered to $24 from $32 at Mizuho
FORG ForgeRock
$22.24 /

-1.13 (-4.84%)

  • 16
    Sep
FORG ForgeRock
$22.24 /

-1.13 (-4.84%)

Recommendations
Cellebrite price target lowered to $10 from $13 at Cowen » 07:38
08/12/22
08/12
07:38
08/12/22
07:38
CLBT

Cellebrite

$5.28 /

-0.4 (-7.04%)

Cowen analyst Shaul Eyal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLBT Cellebrite
$5.28 /

-0.4 (-7.04%)

CLBT Cellebrite
$5.28 /

-0.4 (-7.04%)

07:14 Today William Blair
Cellebrite downgraded to Market Perform at William Blair after guidance cut
06:06 Today William Blair
Cellebrite downgraded to Market Perform from Outperform at William Blair
05/16/22 Cowen
Cellebrite price target lowered to $13 from $17 at Cowen
05/13/22 Deutsche Bank
Cellebrite price target lowered to $10 from $11 at Deutsche Bank
CLBT Cellebrite
$5.28 /

-0.4 (-7.04%)

CLBT Cellebrite
$5.28 /

-0.4 (-7.04%)

Recommendations
LegalZoom price target lowered to $19 from $24 at Credit Suisse » 07:38
08/12/22
08/12
07:38
08/12/22
07:38
LZ

LegalZoom

$11.11 /

-0.175 (-1.55%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LZ LegalZoom
$11.11 /

-0.175 (-1.55%)

LZ LegalZoom
$11.11 /

-0.175 (-1.55%)

07/28/22 Morgan Stanley
LegalZoom downgraded to Underweight on estimate risk at Morgan Stanley
07/28/22 Morgan Stanley
LegalZoom downgraded to Underweight from Equal Weight at Morgan Stanley
07/14/22 Morgan Stanley
LegalZoom price target lowered to $12 from $13 at Morgan Stanley
04/19/22 Citi
LegalZoom assumed with Buy from Neutral at Citi
LZ LegalZoom
$11.11 /

-0.175 (-1.55%)

LZ LegalZoom
$11.11 /

-0.175 (-1.55%)

Recommendations
Rockley Photonics price target lowered to $14 from $21 at Cowen » 07:37
08/12/22
08/12
07:37
08/12/22
07:37
RKLY

Rockley Photonics

$2.00 /

-0.1 (-4.76%)

Cowen analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RKLY Rockley Photonics
$2.00 /

-0.1 (-4.76%)

RKLY Rockley Photonics
$2.00 /

-0.1 (-4.76%)

06:37 Today Baird
Rockley Photonics downgraded to Neutral from Outperform at Baird
06/08/22
Baird to hold a conference
06/07/22
Baird to hold a conference
05/13/22 Needham
Rockley Photonics price target lowered to $4 from $8 at Needham
RKLY Rockley Photonics
$2.00 /

-0.1 (-4.76%)

RKLY Rockley Photonics
$2.00 /

-0.1 (-4.76%)

RKLY Rockley Photonics
$2.00 /

-0.1 (-4.76%)

RKLY Rockley Photonics
$2.00 /

-0.1 (-4.76%)

Earnings
Axcella Health reports Q2 EPS (40c), consensus (38c) » 07:37
08/12/22
08/12
07:37
08/12/22
07:37
AXLA

Axcella Health

$2.34 /

+ (+0.00%)

As of June 30, cash, cash…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXLA Axcella Health
$2.34 /

+ (+0.00%)

AXLA Axcella Health
$2.34 /

+ (+0.00%)

08/03/22 H.C. Wainwright
Axcella Health price target lowered to $8 from $14 at H.C. Wainwright
05/09/22 Chardan
Axcella Health price target lowered to $7 from $12 at Chardan
10/12/21 Noble Capital
Axcella Health initiated with an Outperform at Noble Capital
09/22/21 Goldman Sachs
Axcella Health downgraded to Neutral from Buy at Goldman Sachs
AXLA Axcella Health
$2.34 /

+ (+0.00%)

Recommendations
Kore Group price target lowered to $9 from $12.50 at Cowen » 07:35
08/12/22
08/12
07:35
08/12/22
07:35
KORE

Kore Group

$2.71 /

-0.03 (-1.09%)

Cowen analyst Lance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KORE Kore Group
$2.71 /

-0.03 (-1.09%)

KORE Kore Group
$2.71 /

-0.03 (-1.09%)

05/17/22 Deutsche Bank
Kore Group price target lowered to $6 from $7.50 at Deutsche Bank
04/12/22 Morgan Stanley
Kore Group price target lowered to $6.50 from $7.50 at Morgan Stanley
04/12/22 Morgan Stanley
Morgan Stanley cuts Telecom & Networking Equipment industry view to Cautious
03/10/22 Cowen
Kore Group price target lowered to $12.50 from $18 at Cowen
KORE Kore Group
$2.71 /

-0.03 (-1.09%)

KORE Kore Group
$2.71 /

-0.03 (-1.09%)

Earnings
Soligenix reports Q2 EPS (6c), consensus (8c) » 07:34
08/12/22
08/12
07:34
08/12/22
07:34
SNGX

Soligenix

/

+

Reports Q2 revenue $0.4M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNGX Soligenix
/

+

SNGX Soligenix
/

+

08/25/21 Alliance Global Partners
Soligenix price target lowered to $3.75 from $5.75 at Alliance Global Partners
Hot Stocks
Marathon Gold reports Q2 capex C$9.2M vs. C$4.7M last year » 07:33
08/12/22
08/12
07:33
08/12/22
07:33
MGDPF

Marathon Gold

$1.55 /

-0.007 (-0.45%)

Matt Manson, President,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MGDPF Marathon Gold
$1.55 /

-0.007 (-0.45%)

MGDPF Marathon Gold
$1.55 /

-0.007 (-0.45%)

07/21/22 National Bank
Marathon Gold price target lowered to C$2.50 from C$3.75 at National Bank
07/07/22 Canaccord
Marathon Gold price target lowered to C$3.50 from C$3.60 at Canaccord
06/14/22 RBC Capital
Marathon Gold price target lowered to C$3.50 from C$4 at RBC Capital
05/16/22 TD Securities
Marathon Gold price target lowered to C$3.50 from C$4 at TD Securities
MGDPF Marathon Gold
$1.55 /

-0.007 (-0.45%)

Recommendations
Taysha Gene Therapies price target lowered to $5 from $9 at Wedbush » 07:33
08/12/22
08/12
07:33
08/12/22
07:33
TSHA

Taysha Gene Therapies

$3.96 /

-0.95 (-19.35%)

Wedbush analyst Laura…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSHA Taysha Gene Therapies
$3.96 /

-0.95 (-19.35%)

TSHA Taysha Gene Therapies
$3.96 /

-0.95 (-19.35%)

05/17/22 Chardan
Taysha Gene Therapies price target lowered to $34 from $37 at Chardan
04/01/22 Truist
Taysha Gene Therapies price target lowered to $35 from $60 at Truist
03/31/22 Chardan
Taysha Gene Therapies price target lowered to $37 from $60 at Chardan
03/09/22 Baird
Baird expects positive GAN guide for Taysha Gene Therapies, starts at Outperform
TSHA Taysha Gene Therapies
$3.96 /

-0.95 (-19.35%)

TSHA Taysha Gene Therapies
$3.96 /

-0.95 (-19.35%)

Recommendations
Fastly price target lowered to $25 from $35 at Raymond James » 07:32
08/12/22
08/12
07:32
08/12/22
07:32
FSLY

Fastly

$11.56 /

-0.275 (-2.32%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FSLY Fastly
$11.56 /

-0.275 (-2.32%)

FSLY Fastly
$11.56 /

-0.275 (-2.32%)

08/04/22 Craig-Hallum
Fastly price target lowered to $13 from $19 at Craig-Hallum
07/22/22 Citi
Fastly price target lowered to $10 from $14 at Citi
07/19/22 RBC Capital
Fastly downgraded to Underperform from Sector Perform at RBC Capital
07/19/22 RBC Capital
Fastly downgraded to Underperform from Sector Perform at RBC Capital
FSLY Fastly
$11.56 /

-0.275 (-2.32%)

FSLY Fastly
$11.56 /

-0.275 (-2.32%)

FSLY Fastly
$11.56 /

-0.275 (-2.32%)

Recommendations
Leafly price target lowered to $4 from $12 at Cowen » 07:32
08/12/22
08/12
07:32
08/12/22
07:32
LFLY

Leafly

$2.25 /

-0.15 (-6.25%)

Cowen analyst Harrison…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LFLY Leafly
$2.25 /

-0.15 (-6.25%)

LFLY Leafly
$2.25 /

-0.15 (-6.25%)

06:12 Today Benchmark
Leafly price target lowered to $6.50 from $12.00 at Benchmark
05/20/22 Cowen
Cowen starts Leafly with Outperform with its early mover advantage
05/20/22 Cowen
Leafly initiated with an Outperform at Cowen
05/18/22 Oppenheimer
Leafly initiated with a Perform at Oppenheimer
LFLY Leafly
$2.25 /

-0.15 (-6.25%)

LFLY Leafly
$2.25 /

-0.15 (-6.25%)

LFLY Leafly
$2.25 /

-0.15 (-6.25%)

Downgrade
Sally Beauty downgraded to Market Perform at Cowen on risk to FY23 estimates » 07:32
08/12/22
08/12
07:32
08/12/22
07:32
SBH

Sally Beauty

$15.20 /

+0.66 (+4.54%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SBH Sally Beauty
$15.20 /

+0.66 (+4.54%)

SBH Sally Beauty
$15.20 /

+0.66 (+4.54%)

05:56 Today Cowen
Sally Beauty downgraded to Market Perform from Outperform at Cowen
06/29/22 Raymond James
Raymond James cuts Sally Beauty to Underperform on exposure low-income consumer
06/29/22 Raymond James
Sally Beauty downgraded to Underperform from Market Perform at Raymond James
06/16/22 Morgan Stanley
Sally Beauty downgraded to Underweight from Equal Weight at Morgan Stanley
SBH Sally Beauty
$15.20 /

+0.66 (+4.54%)

SBH Sally Beauty
$15.20 /

+0.66 (+4.54%)

Downgrade
PagerDuty downgraded to Neutral from Buy at Monness Crespi » 07:31
08/12/22
08/12
07:31
08/12/22
07:31
PD

PagerDuty

$28.13 /

-1.145 (-3.91%)

Monness Crespi analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PD PagerDuty
$28.13 /

-1.145 (-3.91%)

PD PagerDuty
$28.13 /

-1.145 (-3.91%)

07/07/22 Canaccord
PagerDuty initiated with a Buy at Canaccord
06/03/22 Craig-Hallum
PagerDuty price target lowered to $37 from $45 at Craig-Hallum
06/03/22 Baird
PagerDuty price target lowered to $40 from $47 at Baird
05/31/22 RBC Capital
PagerDuty price target lowered to $41 from $46 at RBC Capital
PD PagerDuty
$28.13 /

-1.145 (-3.91%)

PD PagerDuty
$28.13 /

-1.145 (-3.91%)

PD PagerDuty
$28.13 /

-1.145 (-3.91%)

Downgrade
TerrAscend downgraded to Neutral from Overweight at Cantor Fitzgerald » 07:30
08/12/22
08/12
07:30
08/12/22
07:30
TRSSF

TerrAscend

$2.40 /

+0.11 (+4.80%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRSSF TerrAscend
$2.40 /

+0.11 (+4.80%)

TRSSF TerrAscend
$2.40 /

+0.11 (+4.80%)

07/22/22 Seaport Global
TerrAscend initiated with a Buy at Seaport Global
02/09/22 Clarus
TerrAscend price target lowered to C$14 from C$16.25 at Clarus
12/08/21 Cantor Fitzgerald
TerrAscend price target raised to $7.65 from $6.70 at Cantor Fitzgerald
11/17/21 Stifel
TerrAscend price target lowered to C$21 from C$23 at Stifel
TRSSF TerrAscend
$2.40 /

+0.11 (+4.80%)

TRSSF TerrAscend
$2.40 /

+0.11 (+4.80%)

Downgrade
NextNav cut to Perform at Oppenheimer on capital needs » 07:28
08/12/22
08/12
07:28
08/12/22
07:28
NN

NextNav

$3.39 /

+0.02 (+0.59%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NN NextNav
$3.39 /

+0.02 (+0.59%)

NN NextNav
$3.39 /

+0.02 (+0.59%)

06:32 Today Oppenheimer
NextNav downgraded to Perform from Outperform at Oppenheimer
05/16/22 R.F. Lafferty
NextNav price target lowered to $15 from $16 at R.F. Lafferty
05/13/22 B. Riley
NextNav price target lowered to $14.25 from $17 at B. Riley
01/06/22 R.F. Lafferty
NextNav initiated with a Buy at R.F. Lafferty
NN NextNav
$3.39 /

+0.02 (+0.59%)

Recommendations
Toast price target raised to $27 from $21 at Needham » 07:28
08/12/22
08/12
07:28
08/12/22
07:28
TOST

Toast

$18.12 /

-0.33 (-1.79%)

Needham analyst Mayank…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TOST Toast
$18.12 /

-0.33 (-1.79%)

TOST Toast
$18.12 /

-0.33 (-1.79%)

07:17 Today KeyBanc
Toast price target raised to $25 from $18 at KeyBanc
05/17/22 Mizuho
Toast price target lowered to $18 from $19 at Mizuho
05/13/22 Needham
Toast price target lowered to $21 from $38 at Needham
05/13/22 Canaccord
Toast price target lowered to $25 from $34 at Canaccord
TOST Toast
$18.12 /

-0.33 (-1.79%)

  • 22
    Sep
TOST Toast
$18.12 /

-0.33 (-1.79%)

TOST Toast
$18.12 /

-0.33 (-1.79%)

Recommendations
Nkarta price target lowered to $38 from $60 at Cantor Fitzgerald » 07:28
08/12/22
08/12
07:28
08/12/22
07:28
NKTX

Nkarta

$15.59 /

-0.36 (-2.26%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKTX Nkarta
$15.59 /

-0.36 (-2.26%)

NKTX Nkarta
$15.59 /

-0.36 (-2.26%)

07/28/22 Needham
Nkarta initiated with a Buy at Needham
07/18/22 SVB Securities
Nkarta initiated with an Outperform at SVB Securities
04/26/22 Stifel
Nkarta's AML/NHL data 'a positive' for CAR-NK space, says Stifel
04/25/22 Cantor Fitzgerald
Nkarta assumed with an Overweight at Cantor Fitzgerald
NKTX Nkarta
$15.59 /

-0.36 (-2.26%)

  • 26
    Apr
NKTX Nkarta
$15.59 /

-0.36 (-2.26%)

NKTX Nkarta
$15.59 /

-0.36 (-2.26%)

Initiation
Mereo BioPharma initiated with an Overweight at Cantor Fitzgerald » 07:27
08/12/22
08/12
07:27
08/12/22
07:27
MREO

Mereo BioPharma

$1.15 /

-0.055 (-4.56%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MREO Mereo BioPharma
$1.15 /

-0.055 (-4.56%)

MREO Mereo BioPharma
$1.15 /

-0.055 (-4.56%)

06/06/22 Needham
Mereo BioPharma price target lowered to $5 from $10 at Needham
MREO Mereo BioPharma
$1.15 /

-0.055 (-4.56%)

Recommendations
Shattuck Labs price target lowered to $21 from $31 at Needham » 07:26
08/12/22
08/12
07:26
08/12/22
07:26
STTK

Shattuck Labs

$3.68 /

-0.15 (-3.92%)

Needham analyst Chad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STTK Shattuck Labs
$3.68 /

-0.15 (-3.92%)

STTK Shattuck Labs
$3.68 /

-0.15 (-3.92%)

06/01/22 Citi
Shattuck Labs initiated with a Buy at Citi
05/02/22 H.C. Wainwright
Shattuck Labs initiated with a Buy at H.C. Wainwright
STTK Shattuck Labs
$3.68 /

-0.15 (-3.92%)

STTK Shattuck Labs
$3.68 /

-0.15 (-3.92%)

Downgrade
Lennar downgraded to Neutral from Outperform at Wedbush » 07:25
08/12/22
08/12
07:25
08/12/22
07:25
LEN

Lennar

$87.78 /

+0.47 (+0.54%)

Wedbush analyst Jay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LEN Lennar
$87.78 /

+0.47 (+0.54%)

LEN Lennar
$87.78 /

+0.47 (+0.54%)

06:32 Today Wedbush
Lennar downgraded to Neutral from Outperform at Wedbush
07/12/22 JPMorgan
JPMorgan 'cautious and less constructive' on homebuilders, downgrades Lennar
07/12/22 JPMorgan
Lennar downgraded to Neutral from Overweight at JPMorgan
06/22/22 UBS
Lennar price target lowered to $106 from $108 at UBS
LEN Lennar
$87.78 /

+0.47 (+0.54%)

LEN Lennar
$87.78 /

+0.47 (+0.54%)

LEN Lennar
$87.78 /

+0.47 (+0.54%)

LEN Lennar
$87.78 /

+0.47 (+0.54%)

Hot Stocks
GreenLight Bioscences announces $109M financing » 07:25
08/12/22
08/12
07:25
08/12/22
07:25
GRNA

GreenLight Bioscences

$4.00 /

+0.09 (+2.30%)

GreenLight Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GRNA GreenLight Bioscences
$4.00 /

+0.09 (+2.30%)

Hot Stocks
ARC Group says RM2 continues to experience 'record demand' for BLOCKPal pallets » 07:22
08/12/22
08/12
07:22
08/12/22
07:22
ARCW

ARC Group

$1.00 /

+ (+0.00%)

ARC Group Worldwide…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.